CreativeOne Wealth’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
CreativeOne Wealth's DGX Position: Q4 2025 in Review
CreativeOne Wealth sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 6,093 shares — an estimated $1.16M sold.
CreativeOne Wealth first reported a position in DGX in Q4 2020 and held it in 20 quarters. The position peaked at $2.1M in Q2 2023. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- CreativeOne Wealth reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
- CreativeOne Wealth sold 6,093 Quest Diagnostics shares in Q4 2025, an estimated $1.16M.
- CreativeOne Wealth first reported a position in Quest Diagnostics in Q4 2020 and held it in 20 quarters.
- CreativeOne Wealth's Quest Diagnostics position peaked at $2.1M in Q2 2023.
- 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on CreativeOne Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.